These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 17198756)
1. Medroxyprogesterone and tamoxifen augment anti-proliferative efficacy and reduce mitochondria-toxicity of epirubicin in FM3A tumor cells in vitro. Altinoz MA; Bilir A; Gedikoglu G; Ozcan E; Oktem G; Muslumanoglu M Cell Biol Int; 2007 May; 31(5):473-81. PubMed ID: 17198756 [TBL] [Abstract][Full Text] [Related]
2. Autophagy and nuclear changes in FM3A breast tumor cells after epirubicin, medroxyprogesterone and tamoxifen treatment in vitro. Bilir A; Altinoz MA; Erkan M; Ozmen V; Aydiner A Pathobiology; 2001; 69(3):120-6. PubMed ID: 11872957 [TBL] [Abstract][Full Text] [Related]
3. Modulation of epirubicin cytotoxicity by tamoxifen in human breast cancer cell lines. Azab SS; El-Demerdash E; Abdel-Naim AB; Youssef E; El-Sharkawy N; Osman AM Biochem Pharmacol; 2005 Sep; 70(5):725-32. PubMed ID: 16005435 [TBL] [Abstract][Full Text] [Related]
4. The effects of epirubicin hydrochloride (EPI) plus pretreatment of medroxyprogesterone acetate (MPA) on FM3A breast cancer cells transplanted in female C3H/He mice. Yuyama Y; Yagihashi A; Hirata K; Suzuki Y; Ohmura T; Okazaki M; Watanabe N In Vivo; 2003; 17(3):251-4. PubMed ID: 12929575 [TBL] [Abstract][Full Text] [Related]
5. [Does interferon-alpha enhance the effect of tamoxifen-medroxyprogesterone acetate and hydroxyflutamide on in vitro tumor cells?]. Werner A; Aichberger A; Krebs D Zentralbl Gynakol; 1996; 118(11):616-21. PubMed ID: 9082695 [TBL] [Abstract][Full Text] [Related]
6. Medroxyprogesterone acetate induces c6 glioma chemosensitization via antidepressant-like lysosomal phospholipidosis/myelinosis in vitro. Altinoz MA; Gedikoglu G; Sav A; Ozcan E; Ozdilli K; Bilir A; Del Maestro RF Int J Neurosci; 2007 Oct; 117(10):1465-80. PubMed ID: 17729157 [TBL] [Abstract][Full Text] [Related]
7. Supplementation with l-carnitine does not reduce the efficacy of epirubicin treatment in breast cancer cells. Delaney CE; Hopkins SP; Addison CL Cancer Lett; 2007 Jul; 252(2):195-207. PubMed ID: 17275999 [TBL] [Abstract][Full Text] [Related]
8. beta-Sitosterol enhances tamoxifen effectiveness on breast cancer cells by affecting ceramide metabolism. Awad AB; Barta SL; Fink CS; Bradford PG Mol Nutr Food Res; 2008 Apr; 52(4):419-26. PubMed ID: 18338406 [TBL] [Abstract][Full Text] [Related]
9. The DNA-damaging potential of tamoxifen in breast cancer and normal cells. Wozniak K; Kolacinska A; Blasinska-Morawiec M; Morawiec-Bajda A; Morawiec Z; Zadrozny M; Blasiak J Arch Toxicol; 2007 Jul; 81(7):519-27. PubMed ID: 17593413 [TBL] [Abstract][Full Text] [Related]
10. Significance of mitochondrial calcium and nitric oxide for apoptosis of human breast cancer cells induced by tamoxifen and etoposide. Parihar A; Parihar MS; Ghafourifar P Int J Mol Med; 2008 Mar; 21(3):317-24. PubMed ID: 18288379 [TBL] [Abstract][Full Text] [Related]
11. Tamoxifen and TRAIL synergistically induce apoptosis in breast cancer cells. Lagadec C; Adriaenssens E; Toillon RA; Chopin V; Romon R; Van Coppenolle F; Hondermarck H; Le Bourhis X Oncogene; 2008 Feb; 27(10):1472-7. PubMed ID: 17767197 [TBL] [Abstract][Full Text] [Related]
12. Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by downregulating the expression of estrogen related gene products and signal transduction pathways. Chen J; Power KA; Mann J; Cheng A; Thompson LU Nutr Cancer; 2007; 58(2):162-70. PubMed ID: 17640162 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the effect of paclitaxel, epirubicin and tamoxifen by cell kinetics parameters in estrogen-receptor-positive ehrlich ascites tumor (eat) cells growing in vitro. Ozcan Arican G; Ozalpan A Acta Biol Hung; 2007 Mar; 58(1):49-59. PubMed ID: 17385543 [TBL] [Abstract][Full Text] [Related]
14. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen. Chen J; Power KA; Mann J; Cheng A; Thompson LU Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of the MAP kinase activity suppresses estrogen-induced breast tumor growth both in vitro and in vivo. Reddy KB; Glaros S Int J Oncol; 2007 Apr; 30(4):971-5. PubMed ID: 17332937 [TBL] [Abstract][Full Text] [Related]
16. [Effects of carbon-coated iron nanocrystals combined with epirubicin on HepG-2 cells and its acute toxicity in mice]. Zheng Y; Lao XM; Zhang HY; Chen YM; Chen MS; Yuan YF; Zhang YQ; Li JQ Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):176-9. PubMed ID: 18250036 [TBL] [Abstract][Full Text] [Related]
17. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients. Ryberg M; Nielsen D; Cortese G; Nielsen G; Skovsgaard T; Andersen PK J Natl Cancer Inst; 2008 Aug; 100(15):1058-67. PubMed ID: 18664656 [TBL] [Abstract][Full Text] [Related]
18. Tamoxifen-induced activation of p21Waf1/Cip1 gene transcription is mediated by Early Growth Response-1 protein through the JNK and p38 MAP kinase/Elk-1 cascades in MDA-MB-361 breast carcinoma cells. Kim CG; Choi BH; Son SW; Yi SJ; Shin SY; Lee YH Cell Signal; 2007 Jun; 19(6):1290-300. PubMed ID: 17307334 [TBL] [Abstract][Full Text] [Related]
19. Pretreatment with tamoxifen does not change acute epirubicin cardiotoxicity in rats. Schjøtt J; Gjerde J; Kisanga ER; Lien EA Basic Clin Pharmacol Toxicol; 2006 Feb; 98(2):231-4. PubMed ID: 16445601 [No Abstract] [Full Text] [Related]
20. The antipsychotic drug chlorpromazine enhances the cytotoxic effect of tamoxifen in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells. Yde CW; Clausen MP; Bennetzen MV; Lykkesfeldt AE; Mouritsen OG; Guerra B Anticancer Drugs; 2009 Sep; 20(8):723-35. PubMed ID: 19584708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]